Faculty Researchers

Principal Investigator
Karam F.A. Soliman, Ph.D.

E-mail: karam.soliman@famu.edu
Area of Expertise: Flow Cytometry, Insulin, Diabetes, Nanoparticle, Microinfections
Research Interest: Description of Research Interest

Dr. Karam Soliman is a distinguished Professor of Basic Pharmaceutical Sciences at Florida A&M University College of Pharmacy and Pharmaceutical Sciences. He obtained his B.Sc. degree from Cairo University, and he was awarded the M.Sc. degree (1971) and the Ph.D. degree (1972) from the University of Georgia Dr. Soliman’s research interest is in the area of Neuroscience . Among 100 Historically Black Colleges and Universities (HBCU) in the country, Dr. Soliman ranked the top (number one) as the most Science published faculty member.

His publications record includes 146 published research articles, 3 books, 3 US Patents. Dr. Soliman is also the nation’s top trainer of African American holding the Ph.D. degree in Pharmaceutical Sciences. Nationwide, he was the major professor of 30% African American holding the PhD’s in Pharmaceutical Sciences. Dr. Soliman is the Principal Investigator and Program Director of NIH grant to support the FAMU-Pharmacy Research Center in Minority Institution (RCMI). In 2012 . Dr. Soliman received a center P20 Grant over five years from the National Institute on Minority Health and Health Disparities. This grant is entitled: Center of Excellence for Cancer Research, Training and Community Service” . Dr. Soliman research has been supported by grants from NIH, NASA, Office of Naval Research and Department of Energy. During his tenure at FAMU Dr. Soliman was awarded federal grants totaling over $ 64 million. Dr. Soliman is an active member of American Physiology Society (APS), American Society for Pharmacology and Experimental Therapeutics (ASPET), Endocrine Society, and the Society for Neuroscience.

Dr. John Cooperwood
E-mail: john.cooperwood@famu.edu
Area of Expertise: Computer Aided Drug Design (Molecular Modeling), Organic Synthesis, Analytical Methods, Triple Negative Breast Cancer
Research Interest: Description of Research Interest

Dr. Cooperwood’s research interest is in the development of drugs targeting triple negative breast cancer which is a health disparity affecting African American and Hispanic women. Current drugs on the market target only the estrogen receptor positive type which makes up to 80 percent of breast cancer patients. Having received a recent patent (WIPO Patent Application WO/2012/142029 Cooperwood, John S. SERMS FOR THETREATMENT OF ESTROGEN RECEPTOR-MEDIATED DISORDERS) in which our compounds was found later to active against the triple negative breast cancer, we hope to use our computational molecular modeling pharmacophore to develop drugs targeting the triple negative breast cancer based upon 3,3′-Diindolylmethane or DIM compound formed from naturally occurring indole-3-carbinol found in broccoli, cabbage and Brussels sprouts. By participating in this P20 center grant, this effort will be more feasible considering the team of investigators who expertise in the areas pharmacology, molecular biology and pharmaceutics.

Dr. Carl Goodman
E-mail: carl.goodman@famu.edu
Area of Expertise: Real-Time qRT-PCR, Receptor Binding, Flow Cytometry
Research Interest: Crosstalk by Androgen Receptor & Aryl Hydrocarbon Receptor with PhIP; Molecular and Biochemical Basis of Opioid Tolerance; Cocaine-Induced Cytotoxicity; and Morphological Changes & Cytokine Responses Associated with Gestational Cocaine Exposure

Activity Leader for the Student Research Training and Educational Core, Dr. Goodman is responsible for identifying and recruiting outstanding minority candidates, who seeks a strong desire to obtain a doctoral degree in the biomedical sciences with an emphasis in cancer. Dr. Goodman oversees the research assistantships for 5-10 students, as well as provide leadership in developing a curricula to assist our students to gain knowledge in minority health and health disparity; research ethics and responsible conduct in research; and can biology. Dr. Goodman works closely with PI and the other P20 Activity Leaders, who are responsible for the Research Core and Community Service Core to strengthen and manage the Center’s strategic goals by producing a pool of outstanding scientists for careers in cancer research with the ultimate goal of having an impact of addressing minority health and health disparities.

Dr. Mandip Sachdeva
E-mail: mandip.sachdeva@famu.edu
Area of Expertise: Flow Cytometry, Insulin, Diabetes, Nanoparticle, Microinfections
Research Interest: Description of Research Interest

Dr. Sachdeva is a Professor and Section Leader for the Pharmaceutics activity at Florida A&M, College of Pharmacy. He has made significant contributions to the knowledge and understanding in the area of drug delivery with special emphasis in inhalation/aerosol delivery as applied to lung cancer, Triple negative breast cancer and topical delivery of neuropeptides. He has used a multidisciplinary approach of not only delivering novel anticancer agents by inhalation drug delivery but also look into their mechanism of action for newer targets. During the last 20 years, besides developing new approaches for improved drug delivery to the lungs and through the skin, Dr. Sachdeva has identified new molecular pathways and mechanisms for therapeutic agents and nucleic acids intended for the treatment of lung, breast and skin cancer. His work has resulted in over 110 peer reviewed publications and more than 200 presentations in national and international meetings. He is also a fellow of American Association of Pharmaceutical Scientists(AAPS). Presently he serves as the Research Core Director for the P20 activity at Florida A&M.

Saleh M. M. Rahman, M.D., Ph.D., M.P.H
E-mail: saleh.raman@famu.edu
Area of Expertise: Global Health and Medicine, Behavioral Intervention, Program Evaluation, Cost-effectiveness Analysis and CBPR.
Research Interest: Dr. Rahman’s research interests are in health disparities, global health, cancer prevention, childhood obesity prevention, social marketing, CBPR and behavioral epidemiology.

Dr. Saleh Rahman serves as the Director of the Community Outreach and Preventive Services Core (COPS) of the Center. He is Associate Professor of Public Health at the Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University. He also holds a Clinical Research Faculty position at the College of Medicine, Florida State University. As a director of COPS, he oversees the day to day activities of the community outreach core. He is responsible for supervising community Liaison, community advisors, psychologist, program evaluator and graduate assistants working in community outreach core. Dr. Rahman also responsible for developing strategic planning, behavioral interventions, social marketing campaign and media advocacy for preventing cancers in the community by strengthening partnerships with clinical service providers, local and regional community-based organizations, local health offices and policy makers.